TRINEX Tablet is a trusted hemostatic agent containing Tranexamic Acid, available in doses such as 500 mg or 650 mg depending on clinical application. Developed by BluepillExpress, a reputed name in global pharmaceutical third-party manufacturing and exports, this tablet is formulated to deliver reliable antifibrinolytic action, ensuring controlled and efficient management of bleeding disorders.
Tranexamic Acid works by inhibiting the activation of plasminogen to plasmin, thereby preventing fibrin degradation and stabilizing blood clots. It is particularly useful in conditions where excessive fibrinolysis is the root cause of bleeding. As a non-hormonal treatment, it is widely preferred in menorrhagia, epistaxis, tooth extractions, and various surgical or trauma-related bleeding conditions.
Manufacturing Excellence by BluepillExpress:
TRINEX Tablet is produced in WHO-GMP, ISO 9001:2015, and cGMP certified facilities, strictly following Schedule M guidelines. Each batch undergoes meticulous quality checks, including:
Assay and content uniformity testing
Dissolution profiling
Microbial limit tests
Residual solvent analysis
Packaging integrity validation
These robust protocols ensure the purity, potency, and bioavailability of every TRINEX Tablet manufactured for local and international markets.
Pharmacological Profile:
Tranexamic Acid is a synthetic antifibrinolytic agent that exerts its effect by blocking lysine binding sites on plasminogen molecules, thereby reducing the dissolution of fibrin clots. This makes it effective for a wide range of bleeding scenarios without affecting platelet count or clotting time.
Indications:
Heavy menstrual bleeding (Menorrhagia)
Bleeding associated with dental procedures in hemophilia
Epistaxis (nosebleeds)
Postpartum hemorrhage
Surgical bleeding (orthopedic, gynecological, cardiac, etc.)
Hereditary angioedema (off-label use)
Trauma-related internal bleeding (with medical supervision)
Dosage & Administration:
Menorrhagia: 500 mg to 1000 mg three times daily for up to 5 days
Surgical bleeding prevention: 1000 mg prior to surgery, then 3-4 times daily post-op
Dental extraction in hemophiliacs: As per specialist recommendation
Note: Dosage should be customized by a healthcare professional based on the bleeding condition, renal function, and patient history.
Why Choose TRINEX Tablet by BluepillExpress:
Non-hormonal treatment for menstrual bleeding
No interference with ovulation or fertility
Minimizes need for blood transfusion postoperatively
High oral bioavailability and gastric tolerability
Bulk manufacturing and custom branding available
Product Packaging & Export-Ready Compliance:
BluepillExpress offers TRINEX in blister or strip packing, typically:
10 tablets per strip
Aluminum-PVC or Alu-Alu packaging
Multilingual labels and patient information leaflets
Compliant with country-specific registration and regulatory needs
With international experience in supplying to Asia, Africa, CIS, Middle East, and Latin America, BluepillExpress ensures complete documentation including:
Certificate of Analysis (COA)
Certificate of Pharmaceutical Product (COPP)
MSDS
Stability Data
Product Dossier (CTD/eCTD format on request)
Precautions & Contraindications:
Use with caution in patients with renal impairment (dose adjustment required)
Not recommended in patients with active thromboembolic disease
May cause mild side effects like nausea, diarrhea, headache, or visual disturbances
Avoid in patients with a history of seizures
Description provided by bluepill express.
FIEO Registered
Export Ready
